Orfit Industries America has received the US Food and Drug Administration clearance to market its Nanor hybrid thermoplastic technology for use in an immobilization mask for radiation therapy.
The company estimates that immobilization products using the advanced technology will become available for sale in the US during the first half of 2014.
Orfit’s advanced nano-technology will be used in the company’s new Nanor masks, creating a mask that is 33-50% thinner than conventional masks. These masks exhibit much less shrinkage and are light yet stable, ultimately increasing patient comfort.
Since the mask better conforms to a patient’s head, it provides higher stability during radiation therapy. The nano technology-enhanced masks are also better for the environment, as they use less material and create less waste.
Nanor hybrid thermoplastic technology is a new application in radiation oncology to enable enhanced patient comfort, treatment precision, environmental benefits.
Orfit Industries manufactures low temperature thermoplastics, hardware and accessories for patient immobilization and positioning in radiation oncology.